135.83USD-4.61%Mkt Cap: 8.93B $P/E: —Today
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food…
Industry Peers
Diagnostics & ResearchKey Statistics
Company
Market Cap8.93B $
Enterprise Value8.49B $
Revenue (TTM)431.80M $
Gross Profit191.00M $
Net Income (TTM)-77.67M $
Revenue/Share7.032 USD
Last Price135.83 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees979
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS90184D1000
Valuation
P/E (Trailing)—
P/E (Forward)-215.26
PEG—
EV/EBITDA-73.65
EV/Revenue19.66
P/S19.80
P/B19.17
EPS (TTM)-2.14
EPS (Forward)-0.63
52W Range
23.3094% of range142.84
52W High142.84 USD
52W Low23.30 USD
Profitability
Gross Margin50.72%
Oper. Margin-30.65%
EBITDA Margin-26.70%
Profit Margin-20.63%
ROE-16.42%
ROA-12.10%
Growth
Revenue Growth23.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-47.63M $
CapEx (TTM)28.00M $
FCF Margin-15.01%
FCF Yield-0.73%
Net Debt-58.25M $
Net Debt/EBITDA0.51
Balance Sheet
Debt/Equity0.16
Current Ratio2.67
Quick Ratio1.98
Book Value/Sh7.112 USD
Cash/Share2.661 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)105.30 USD
Upside (mean)-22.5%
Target Range36.00 USD – 120.00 USD
$36.00-22.5% to mean$120.00
# Analysts10
Ownership
Shares Out.62.71M
Float61.20M
Insiders1.08%
Institutions115.98%
Short Interest
Short Ratio10.1d
Short % Float28.74%
Short % Out.22.45%
Shares Short14.08M
Short (prev mo.)13.95M
Technical
SMA 5098.41 (+38.0%)
SMA 20058.72 (+131.3%)
Beta2.16
S&P 52W Chg18.16%
Avg Vol (30d)1.52M
Avg Vol (10d)1.71M
Technical Indicators
RSI (14)74.7
MACD10.8909
MACD Signal8.2452
MACD Hist.+2.6456
BB Upper141.35 USD
BB Middle107.22 USD
BB Lower73.10 USD
BB Width63.66%
ATR (14)8.383 USD
Vol Ratio (20d)2.32x